MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
447.38
-2.14
-0.48%
Pre Market: 446.62 -0.76 -0.17% 07:22 12/19 EST
OPEN
449.74
PREV CLOSE
449.52
HIGH
452.63
LOW
445.41
VOLUME
15
TURNOVER
331.78M
52 WEEK HIGH
519.68
52 WEEK LOW
362.50
MARKET CAP
113.51B
P/E (TTM)
31.43
1D
5D
1M
3M
1Y
5Y
1D
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026?
NASDAQ · 2h ago
Best Defensive Stocks To Balance Tech Sector Volatility
Seeking Alpha · 1d ago
Vertex Pharmaceuticals (VRTX) Receives a Buy from Scotiabank
TipRanks · 1d ago
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
NASDAQ · 1d ago
Vertex Pharmaceuticals (VRTX): Valuation Check After Positive Pediatric CASGEVY Data and Priority FDA Review Voucher
Simply Wall St · 2d ago
SCHX, TJX, LOW, VRTX: Large Inflows Detected at ETF
NASDAQ · 2d ago
Harbor Capital Appreciation Fund Q3 2025 Portfolio Review
Seeking Alpha · 3d ago
12 Days of Investing: My Top 12 Stocks to Buy Before 2026
The Motley Fool · 3d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.